Recommendations for defining giant cell arteritis fast-track clinics. English version
2024

Recommendations for Giant Cell Arteritis Fast-Track Clinics

publication Evidence: high

Author Information

Author(s): Wolfgang A. Schmidt, Michael Czihal, Michael Gernert, Wolfgang Hartung, Bernhard Hellmich, Sarah Ohrndorf, Gabriela Riemekasten, Valentin S. Schäfer, Johannes Strunk, Nils Venhoff

Hypothesis

What are the optimal requirements for defining fast-track clinics for the diagnosis of giant cell arteritis?

Conclusion

The establishment of fast-track clinics can significantly reduce the risk of permanent blindness in patients with giant cell arteritis.

Supporting Evidence

  • Fast-track clinics have reduced the proportion of permanent blindness in newly diagnosed GCA cases from 19-37% to 2-13%.
  • Ultrasound expertise and quality equipment are widely available in German rheumatology.
  • New regulations for rheumatology training in Germany include vascular ultrasound for acute diagnosis of vasculitis.

Takeaway

Doctors want to make it easier and faster for patients with a serious condition called giant cell arteritis to get help, so they created a list of things these special clinics should have.

Methodology

A team of experts developed recommendations through web conferences and email communication.

Potential Biases

Potential conflicts of interest due to authors' affiliations with pharmaceutical companies.

Limitations

No national or international consensus statement defining fast-track clinics precisely exists.

Digital Object Identifier (DOI)

10.1007/s00393-024-01532-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication